Group Leader, Laboratory of Metabolic Dynamics in Cancer
Informació de contacte
Departament de Biologia Cel·lular, Fisiologia i Immunologia
Parc Científic de Barcelona, S1B53 Institut de Biomedicina de la Universitat de Barcelona (IBUB) +34 93 403 71 66 csebastian(a)ub.edu
Formació acadèmica
Bioquímica
. Universitat de Barcelona
. (Diplomatura / Llicenciatura / Grau)Bioquímica/Immunologia
. Universitat de Barcelona
. (Doctorat )
Linies de Recerca
Metabolic regulation of stem cell fate during tissue homeostasis and tumorigenesisMetabolic heterogeneity and evolution of cancerImmunometabolism in the tumor microenvironment
Projectes
A study on the mechanisms through which tumor cells escape intrinsic and extrinsic control systems
.
2017 - 2020
. Ref.MIUR 2011/2014-STAR
. Fondazione Piemontese per la Ricerca sul Cancro (FPRC)
. IP: Carlos Sebastián Metabolic dynamics of colorectal cancer
.
2018 - 2020
. Ref.797464
. European Commission
. IP: Carlos Sebastián The role of metabolic reprogramming in driving colorectal carcinoma by regulating stemness and tumorigenesis in the intestine
.
2020 - 2022
. Ref.GR-2018-12365776
. Ministerio della Salute
. IP: Carlos Sebastián MIUR 5x1000-STRATEGY
.
2020 - 2022
. Fondazione Piemontese per la Ricerca sul Cancro (FPRC)
. IP: Carlos Sebastián The role of SIRT6 in metabolic reprogramming during colorectal carcinoma
.
2013 - 2016
. Ref.CA120342
. Department of Defense. USA
. IP: Carlos Sebastián
Publicacions en revistes
Kowalik MA, Puliga E, Cabras L, Sulas P, Petrelli A, Perra A, Ledda-Columbano GM, Morandi A, Merlin S, Orrù C, Sanchez-Martin C, Fornari F, Gramantieri L, Parri M, Rasola A, Bellomo SE, Sebastian C, Follenzi A, Giordano S, Columbano A.(2020).
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming.Journal of Hepatology. ISSN: 0168-8278La Vecchia S, Sebastián C.(2019).
Metabolic pathways regulating colorectal cancer initiation and progression.Seminars in Cell & Developmental Biology. ISSN: 1084-9521Sebastián C, Mostoslavsky R.(2017).
The Various Metabolic Sources of Histone Acetylation.Trends in Endocrinology and Metabolism. ISSN: 1043-2760Kugel S, Sebastián C, Fitamant J, Ross KN, Saha SK, Jain E, Gladden A, Arora KS, Kato Y, Rivera MN, Ramaswamy S, Sadreyev RI, Goren A, Deshpande V, Bardeesy N, Mostoslavsky R.(2016).
SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b.Cell. ISSN: 0092-8674Sebastián C, Mostoslavsky R.(2015).
The role of mammalian sirtuins in cancer metabolism.Seminars in Cell & Developmental Biology. ISSN: 1084-9521Sebastián C, Mostoslavsky R.(2014).
Untangling the fiber yarn: butyrate feeds Warburg to suppress colorectal cancer.Cancer Discovery. ISSN: 2159-8274Sebastian C.(2014).
Tracking down the origin of cancer: metabolic reprogramming as a driver of stemness and tumorigenesis.Critical Reviews in Oncogenesis. ISSN: 0893-9675Masri S, Rigor P, Cervantes M, Ceglia N, Sebastian C, Xiao C, Roqueta-Rivera M, Deng C, Osborne TF, Mostoslavsky R, Baldi P, Sassone-Corsi P.(2014).
Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism.Cell. ISSN: 0092-8674Sebastián C, Zwaans BM, Silberman DM, Gymrek M, Goren A, Zhong L, Ram O, Truelove J, Guimaraes AR, Toiber D, Cosentino C, Greenson JK, MacDonald AI, McGlynn L, Maxwell F, Edwards J, Giacosa S, Guccione E, Weissleder R, Bernstein BE, Regev A, Shiels PG, Lombard DB, Mostoslavsky R.(2012).
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.Cell. ISSN: 0092-8674Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, Guimaraes A, Marinelli B, Wikstrom JD, Nir T, Clish CB, Vaitheesvaran B, Iliopoulos O, Kurland I, Dor Y, Weissleder R, Shirihai OS, Ellisen LW, Espinosa JM, Mostoslavsky R.(2010).
The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha.Cell. ISSN: 0092-8674